The mutation of the company
With publication in the Commercial Register on July 6th the transformation of Alemnis from a limited liability into a joint stock company is official. At the same time Jean-Marc Breguet, the company’s current CEO, was also named head of the supervisory board. A number of silent shareholders left the company’s board.
The mutation of the company coincides with a renewed strategic focus on developing the world’s most versatile, high performing and cost-effective nanoindentation platform for in-situ in-SEM and in-air use. Fresh capital was injected to continue the expansion of the innovative product offering.